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Neurons rely heavily on axonal transport to deliver materials from the sites of synthesis to the
axon terminals over distances that can be many centimetres long. KIF1A is the neuron-speciﬁc
kinesin with the fastest reported anterograde motor activity. Previous studies have shown that
KIF1A transports a subset of synaptic proteins, neuroﬁlaments and dense-core vesicles. Using
two-colour live imaging, our study showed that beta-secretase 1 (BACE1)-mCherry moves together
with KIF1A-GFP in both the anterograde and retrograde directions in superior cervical ganglions
(SCG) neurons. Our study conﬁrmed that KIF1A is functionally required for BACE1 transport by
using KIF1A siRNA and a KIF1A mutant construct (KIF1A-T312M) to impair its motor activity. We
further identiﬁed several cargoes that have little or no co-migration with KIF1A-GFP and also move
independently from BACE1-mCherry. Together, these ﬁndings support a primary role for KIF1A in
the anterograde transport of BACE1 and suggest that axonally transported cargoes are sorted into
different classes of carrier vesicles in the cell body and are transported by cargo-speciﬁc motor pro-
teins through the axon.
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1 | INTRODUCTION
The kinesin superfamily proteins (KIFs) are a large gene family of
microtubule-dependent motors; over 45 members have been identi-
ﬁed in the mammalian genome.1 A wide array of cellular cargoes are
simultaneously transported within an axon by different motor pro-
teins, including transport vesicles, membranous organelle and non-
membranous cargoes such as cytoskeletal ﬁlaments, cytosolic protein
complexes and messenger RNAs.2 As motor-cargo interactions are
speciﬁc, it is difﬁcult to recognise the speciﬁc cargoes of a motor pro-
tein among the multitude of other cargoes that are present in the
sheer volume of axons.3 As the types of cargo greatly outnumber the
motors, motors must recognise and carry more than one type of
cargo for efﬁcient transport, but there appears also to be some redun-
dancy in which motor protein carries which cargo. The identiﬁcation
of the cargoes that each motor carries is one of the most poorly
developed areas in the ﬁeld of microtubule-dependent trafﬁcking.4
Previous studies addressing this question have been largely depend-
ent on co-immunoprecipitation strategies. These studies have led to
the identiﬁcation of important binding partners,5–8 but with two
major caveats. First, as stationary material will also be precipitated,
this approach alone does not show that a motor actually moves the
associated cargo. Second, this method may fail to pull-down membra-
nous cargoes that do not interact directly with the motor protein,
especially if the membranes are disrupted during extraction. Transient
interactions with motor protein during transport may also be missed.
Alternative methods to address this question, such as co-migration
analysis in live imaging and the effect of motor protein depletion on
cargo movement, have been relatively little used.
KIF1A belongs to the Kinesin-3 family.9 KIF1A is a neuron-
speciﬁc kinesin and it also has the fastest reported anterograde motor
activity.10 It is suggested to act as a monomer,11 although Hammond
et al reported that KIF1A motors exist in a dimeric state and only
dimerized motors display ATP-dependent processive motility.12 Previ-
ous studies have shown that KIF1A transports a subset of synaptic
proteins1,4 and dense-core vesicles.13 However, the identity of other
cargoes carried by KIF1A is still largely unknown. As a good live
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imaging method is already available for KIF1A,14 we decided to study
which cargoes co-migrate with this motor in dissociated superior cer-
vical ganglions (SCG) neurons. SCG neurons have been used exten-
sively to study axonal transport, largely because the polarity of cell
processes (axons vs dendrites) can be easily determined in the
absence of markers. This, together with their convenient genetic
manipulation by microinjection,15 provides us with a good in vitro
model for evaluating transport kinetics, such as the percentage of
moving vesicles and the average and maximum velocities in both the
anterograde and retrograde directions.
The deposition of amyloid β (Aβ) peptide is the major pathological
hallmark of Alzheimer’s disease. Beta-site amyloid precursor protein
(APP) cleaving enzyme 1 [beta-secretase 1 (BACE1)], a transmembrane
aspartyl protease, initiates the processing of the APP during Aβ genera-
tion and therefore is the rate-limiting enzyme in the amyloidogenic
pathway.16 As APP and BACE1 are highly expressed in neurons, it is
reasonable to assume there should be a mechanism that segregates the
transport of APP and BACE1 to prevent overproduction of Aβ. Despite
extensive research, the problem of where wild-type APP and BACE1
meet and the location of the β-cleavage site remain controversial. Previ-
ous studies have suggested that APP is transported in the same axonal
vesicle as BACE1 and γ-secretase, that APP can then be cleaved by
them, and consequently Aβ is produced in these vesicles.17 This view,
however, has been challenged by several studies. A ligation experiment
on sciatic nerves found that APP is not co-transported with BACE1.18
This ﬁnding was further supported by a video microscopy study show-
ing that APP is transported on a vesicle distinct from BACE1.19 A recent
study using an optical assay, however, found that APP and BACE1 were
co-transported in axons and that they interacted during transit.20
Understanding axonal BACE1 transport is important because abnormal
accumulation of BACE1 at the presynaptic terminals has been reported
in post-mortem AD brain.21 This ﬁnding suggests that elevation of local
BACE1 level could promote the generation of Aβ and this could contrib-
ute to the development of AD.22 However, the molecular players
involved in BACE1 transport in axons are still not completely identiﬁed.
In this study, we ﬁrst characterized the axonal transport of a panel
of cargo candidates, ranging from signalling molecules to proteins that
are involved in neurodegenerative disorders. Two-colour live imaging
showed that BACE1-mCherry moves together with KIF1A-GFP in both
the anterograde and retrograde directions. We identiﬁed several car-
goes that show little or no co-migration with KIF1A-GFP and demon-
strated that these also move independently from BACE1-mCherry. Our
ﬁndings support a primary role for KIF1A in the anterograde transport
of BACE1 and suggest the existence of independently moving groups
of cargoes in neurons. KIF1A is only responsible for the transport of a
sub-population of these moving cargoes.
2 | RESULTS
2.1 | Identiﬁcation of axonally transported
cargoes that can be easily tracked in SCG axons
using live imaging
The aim of this study was to identify the cargoes that KIF1A carried.
Therefore we ﬁrst identiﬁed cargoes that can be easily tracked in
SCG axons using live cell imaging. We visualized the axonal transport
of a panel of cargoes chosen from different categories, ranging from
signalling molecules to proteins that are involved in neurodegenera-
tive disorders (see Table 1). We ﬁrst fused each cargo to a ﬂuores-
cent tag (either mCherry or RFP). We then microinjected a low level
of construct encoding ﬂuorescently labelled protein into the nuclei of
7DIV SCG dissociated cultures and visualized the transport of the
ﬂuorescently labelled protein in the axons at 37C 6-8 hours after
microinjection (schematic in Figure 1A). Microinjected cells that
appeared healthy by phase-contrast were imaged by video micros-
copy. To determine whether the use of microinjection can physically
damage the injected cells and thus affect vesicle motility, we evalu-
ated the velocity and directionality of the lysosomes in the axons of
cells injected with a GFP construct and uninjected cells in the same
dish. Movement of the lysosomes was tracked using the acidotrophic
probe LysoTracker Red DND-99. Our data show that the direction,
velocity and number of moving lysosomes in both the anterograde
and retrograde directions are similar in the cells that have been
injected as in uninjected cells (Figure 1B,C).
Of the 14 cargo candidates that we tested 6 showed a punctate
structure that moved bidirectionally within the axons so movement
along the axon could be represented by kymographs. Interestingly, all
six cargoes whose movements can be tracked easily are involved
either in neurodegenerative diseases or neurodegeneration. For
example, both NMNAT2 (Nicotinamide Nucleotide Adenylyltransfer-
ase 2) and SCG10 (superior cervical ganglia-10) are involved in the
Wallerian degeneration pathway. NMNAT2, which shares the same
NAD-synthesizing enzyme activity with WLDS (slow Wallerian degen-
eration protein), is now well established as an essential survival factor
that prevents spontaneous degeneration of healthy axons. Its con-
stant replenishment from the cell body into axons by anterograde
transport is essential for axon survival and its speciﬁc depletion is
sufﬁcient to induce Wallerian degeneration.15
Surprisingly, we found that most of the signalling molecules
showed a diffuse signal throughout the axons, so their movements
could not be easily tracked. These diffuse signals may have occurred
because the majority of the ﬂuorescently labelled molecules were
unattached and could diffuse freely through the axon. These unat-
tached cargoes lead to high background noise that makes it particu-
larly difﬁcult to track any individual microtubule-dependent moving
vesicles.23
2.2 | KIF1A has a high percentage of
co-migration with BACE1
Next, we wanted to ﬁnd the cargoes that co-migrate with KIF1A.
Toward this, we microinjected dissociated SCG cultures with low
levels of KIF1A-GFP/Cargo candidates-RFP (or mCherry) and simulta-
neously visualized their transport in axons 6-8 hours after microinjec-
tion where the orientation of the axons in relation to the cell body
was unambiguous (schematic in Figure 1A). This is the time when
these ﬂuorescently labelled proteins are just beginning to be
expressed and the ﬂuorescent protein signals are at relatively low
levels. This could avoid the problem of artefacts, which are produced
by high levels of expression. To demonstrate this pattern, we
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measured the average ﬂuorescent intensity of neurites at three dif-
ferent time points after microinjection (6, 24 and 48 h) and have pre-
sented images captured at these time points in Figure S1B,
Supporting Information. We found that there was an increase in ﬂuo-
rescent intensity with time after microinjection. At 6 hours, the aver-
age level of ﬂuorescent intensity was relatively low compared to its
levels at 24 or 48 hours (Figure S1C). In addition, to ensure that the
signals from the GFP and RFP channels are comparable, we gener-
ated line ﬂuorescent intensity proﬁles along the axon co-expressing
NMNAT2-GFP and NMNAT2-mCherry. The proﬁles generated from
the GFP and RFP channels are quantitatively similar in terms of ﬂuo-
rescent peak locations (Figure S2).
To analyse the extent of co-migration between KIF1A-GFP and
cargo candidates, kymographs were generated for each channel (GFP
and RFP/mCherry) and for their overlays (Figure 2A). To quantify the
extent of co-migration, only particles that moved during at least part
of the time-lapse recording were taken into account. The percentage
of co-migration in the axon was then analyzed by comparing pairs of
kymographs generated for each ﬂuorescently tagged cargo. We
found that KIF1A had a different percentage of co-migration with dif-
ferent cargo candidates (Figure 2B): It had the highest percentage of
co-migration with BACE1 but a relatively low percentage of co-
migration with both NMNAT2 and mitochondria. BDNF, APP and
SCG10 all showed intermediate levels of co-migration with KIF1A,
with BDNF being most strongly associated of these.
2.3 | KIF1A is functionally required for the
transport of BACE1-mCherry
The demonstration of a high percentage of co-migration between
KIF1A-GFP and BACE1-mCherry raised the question of whether
KIF1A is functionally required for transporting BACE1 or whether
other motor proteins can substitute when KIF1A activity is removed.
To address this question, we ﬁrst asked whether the transport of
BACE1 vesicles could be disrupted by the expression of a mutant
kinesin construct. We expressed a KIF1A-GFP mutant with a point
mutation (Thr-312 to Met) that impairs the motor domain activity
(KIF1A-T312M-GFP) in dissociated SCG neurons. This point mutation
occurs in the α-helix 5 in KIF1A that is close to the centre of the sur-
face for binding microtubules.24 It impairs the motor activity by inter-
rupting the interactions between the microtubules and kinesin. We
observed that most of the KIF1A-T312M particles were localized in
TABLE 1 Summary of 14 different axonally transported cargoes that have been tested in this study and their nature of movements in SCG
neurite
Category Name of cargo candidate Brief functional description
Nature of
movement
in SCG neurites Reference
Signalling Mitogen-activated protein kinase
kinase 1 (MAP2K1)
Mitogen-activated protein kinase
kinase 5 (MAP2K5)
An essential component of the MAP kinase signal
transduction pathway. Regulate diverse cellular
programmes including embryogenesis, proliferation,
differentiation and apoptosis
Diffuse
Diffuse
53
Bcl-2-interacting mediator of cell
death (BIM)
A member of the BH3-only proapoptotic Bcl-2 family.
Induced in cerebellar granule neurons (CGNs)
undergoing apoptosis
Diffuse 54
c-Jun NH2-terminal kinase I (JNKI) Required for embryonic morphogenesis and this
signalling pathway contributes to the regulation of
cell proliferation and apoptosis
Diffuse 55
c-Jun NH2-terminal kinase II (JNKII) Diffuse
c-Jun NH2-terminal kinase III
(JNKIII)
Diffuse
Microtubule-associated protein
1A/1B-light chain 3 (LC3)
A mammalian homologue of yeast Atg8 (Aut7/Apg8)
and serves as a marker protein for autophagosomes
Diffuse 56
Neurodegeneration Nicotinamide mononucleotide
adenylyltransferase 2 (NMNAT2)
A labile axon survival factor whose constant
replenishment by anterograde axonal transport is a
limiting factor for axon survival
Punctate 57
Superior cervical ganglia-10
(SCG10)
A neuron-speciﬁc stathmin protein with a potent
microtubule destabilizing factor and is enriched in
the growth cones of the developing neurons
Punctate 58
Diseases
associated
Amyloid precursor protein (APP) Takes a central position in Alzheimer’s disease
(AD) pathogenesis: APP processing generates the
β-amyloid (Aβ) peptides, which are deposited as the
amyloid plaques in brains of AD individuals
Punctate 59
Beta-secretase 1 (BACE1) A membrane-bound enzyme that cleaves full-length
APP at the β-secretase cleavage site
Punctate 60
Brain-derived neurotrophic factor
(BDNF)
A type of neurotrophins that are important regulators
of neural survival, development, function, and
plasticity
Punctate 61
Superoxide dismutase 1 (SOD1) Act as antioxidant enzymes whose main role is to
intercept and inactivate reactive oxygen species
Diffuse 62
Organelle Mitochondria An organelle found in large numbers in most cells, in
which the biochemical processes of respiration and
energy production occur
Punctate
SCG, superior cervical ganglions.
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the cell body, and the GFP signal was more restricted to the proximal
sections of the axons (Figure S3A). At distances greater than approxi-
mately 8 μm from the cell body, a signiﬁcant decrease in GFP ﬂuores-
cence was observed in neurites expressing KIF1A-T312M-GFP
compared with those expressing wild-type KIF1A-GFP (Figure S3B).
Consistent with previously published data,14 the number of KIF1A-
T312M-GFP moving particles was also signiﬁcantly reduced in both
directions compared with wild-type KIF1A-EGFP (Figure S3C).
When KIF1A-T312M-GFP was expressed with BACE1-mCherry,
there was a signiﬁcant reduction in the number of BACE1-mCherry
moving particles in both the anterograde and retrograde directions.
We believe that this mutant acts by exerting a dominant negative
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FIGURE 1 (A) Schematic diagram for axonal transport experiments. Dissociated superior cervical ganglions (SCG) neurons were microinjected
with GFP-tagged KIF1A with different cargo candidates constructs, vesicle transport in axons was imaged live after 6-8 hours, and resultant
kymographs were analyzed. (B) Average speed of moving lysosomes (μm/seconds) in cells injected with a GFP construct (n = 19 neurites) and
uninjected cells (n = 11 neurites). Error bars indicate standard error of the mean (SEM). (C) Quantiﬁcation of the number of moving lysosomes in
injected (n = 19 neurites) cells and uninjected cells (n = 11 neurites). Error bars indicate SEM. The direction, velocity and number of moving
lysosomes in both the anterograde and retrograde directions are similar in the cells that have been injected as in uninjected cells.
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FIGURE 2 (A) Co-migration with KIF1A-GFP was analyzed using kymographs (time-distance graphs) obtained from live imaging of axons from
dissociated superior cervical ganglions (SCG) neurons. Representative kymographs from axons co-labelled with KIF1A-GFP and (a) amyloid
precursor protein (APP)-mCherry (b) beta-secretase 1 (BACE1)-mCherry (c) BDNF-mCherry (d) NMNAT2-mCherry (e) mitochondria-RFP (f )
SCG10-mCherry. (B) Quantiﬁcation of co-migration with KIF1A-GFP. The quantiﬁcation shown for each construct represents the percentage of
moving vesicles that co-migrate with KIF1A-GFP. [amyloid precursor protein (APP): n = 18 neurites, beta-secretase 1 (BACE1): n = 22 neurites,
BDNF: n = 21 neurites, MITO: n = 21 neurites, nicotinamide nucleotide adenylyltransferase 2 (NMNAT2): n = 10 neurites, SCG10: n = 14
neurites). Error bars indicate standard error of the mean (SEM)].
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action on endogenous KIF1A by competing with endogenous KIF1A
to bind to BACE1 (Figure 3A,B). However, the expression of KIF1A-
TM-GFP had no effect on the axonal transport of mitochondria
(Figure 3A,B), which was previously found to be a cargo of KIF1B25
and KIF526–29 and have 0% of co-migration with KIF1A (Figure 2B).
Further, to test whether endogenous BACE1 distribution is
affected; we monitored the axonal distribution of BACE1 in neurons
expressing KIF1A-T312M using immunohistochemistry. Compared to
the control, there was a shift of BACE1 protein from neurites to cell
bodies (Figure 4A), suggesting that the transport of endogenous
BACE1 was impaired. However, the expression of mutant KIF1A
protein did not appear to affect the localisation of endogenous APP,
which had a relatively low percentage of co-migration with KIF1A
(Figure 2B). APP protein was still observed in both the cell body and
axonal compartment (Figure 4B).
Second, we asked whether the depletion of endogenous KIF1A
could affect the axonal transport of BACE1 vesicles. We imaged the
axonal transport of BACE1-mCherry in axons co-expressing siRNA
against KIF1A. We observed a signiﬁcant reduction in BACE1-
mCherry moving particles 48 hours after microinjection compared to
cells either without siRNA or with non-targeting (control) siRNA
(Figure 5A,B). To further show the speciﬁcity of our siRNA, we also
A
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FIGURE 3 (A) KIF1A-T312M-GFP reduces the transport of beta-secretase 1 (BACE1) vesicles signiﬁcantly in axons of dissociated superior
cervical ganglions (SCG) neurons. Representative kymographs comparing transport of BACE1-mCherry between (a) KIF1A-WT-GFP and
(b) KIF1A-T312M-GFP expressing neurons. Representative kymographs comparing transport of mito-RFP between (c) KIF1A-WT-GFP and
(d) KIF1A-T312M-GFP expressing neurons. (B) Quantiﬁcation of the number of moving BACE1-mCherry particles (alone: n = 18, with KIF1A-
WT-GFP: n = 17, with KIF1A-T312M-GFP: n = 23, ****P ≤ .0001, t-test) (bottom left panel). Quantiﬁcation of the number of moving
mitochondria-RFP particles (alone: n = 10, with KIF1A-WT-GFP: n = 28, with KIF1A-T312M-GFP: n = 32) (bottom right). Error bars indicate
standard error of the mean (SEM).
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looked at the axonal transport of mitochondria in neurons expressing
KIF1A siRNA. We found that the axonal transport of mitochondria is
not affected by the non-targeting siRNA (control) or knocking down
of KIF1A protein (Figure 5A,B). These ﬁndings suggest that KIF1A
activity is functionally required for the transport of BACE1-mCherry.
2.4 | BACE1, NMNAT2 and mitochondria are
transported in distinct carriers
We previously reported that NMNAT2 and mitochondria move inde-
pendently of one another.30 Interestingly, our data showed that both
NMNAT2 and mitochondria also have a very low percentage of co-
migration with KIF1A-GFP (Figure 2B). This prompted us to ask
whether BACE1 is transported by a different carrier from those carrying
either NMNAT2 or mitochondria as this may suggest the existence of
several independently moving groups of cargoes. We examined the per-
centage co-migration of BACE1-mCherry with NMNAT2-GFP and also
the percentage co-migration of BACE1-mCherry with Mitochondria-
RFP using live imaging of each pair of cargoes in the same axon.
In SCGs neurons co-injected with BACE1-mCherry and
NMNAT2-GFP (Figure 6A), the localisation of mobile BACE1 and
NMNAT2 was mostly non-overlapping. Consecutive images from a
2.5-second time-lapse series are shown in Figure 6B with yellow
arrowheads in the GFP channel (Figure 6B) marking an anterogradely
moving NMNAT2-GFP vesicle not containing BACE1-mCherry. Grey
arrowheads in the RFP channel (Figure 6B) mark an anterogradely
moving BACE1-mCherry vesicle not containing NMNAT2-GFP. Thus,
these particular vesicles moving BACE1 and NMNAT2 are
transported by distinct carriers and the quantiﬁcation (Figure 7B)
shows this is typical of the large majority of such vesicles. Similar
results were found when BACE1-GFP and mito-RFP were co-injected
(Figure 7A). Yellow arrowheads in the GFP channel (Figure 7A) mark
an anterogradely moving BACE1-GFP vesicle not containing RFP and
grey arrowheads in the RFP channel (Figure 7A) mark an anterogra-
dely moving mitochondria not containing GFP. Thus, BACE1 and
mitochondria are also moving independently from one another.
We also compared the transport kinetics of mobile BACE1-
mCherry/NMNAT2-mCherry/Mitochondria-RFP vesicles using a plugin
developed by our group in the software IMAGEJ.31 Subtle differences
were recorded in their average and maximum velocity in both the anter-
ograde and retrograde directions (Figure 8A), especially for moving mito-
chondria which was the slowest of these cargoes in both anterograde
and retrograde direction (summarized in Table 2). Taken together, these
ﬁndings suggest that BACE1, NMNAT2 and mitochondria are trans-
ported in distinct carriers and that KIF1A is a selective kinesin responsi-
ble for moving one group of independently moving cargoes in axons.
3 | DISCUSSION
3.1 | BACE1, NMNAT2 and Mitochondria are
markers for non-overlapping components of axonal
transport
The live imaging technique was introduced in the late 1980s to
overcome the limitations of using whole-nerve radiolabelling in
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FIGURE 4 KIF1A-T312M-GFP impairs axonal
transport of endogenous beta-secretase 1 (BACE1)
but not amyloid precursor protein (APP). KIF1A-
T312M-GFP expressing neurons or control were
immunostained for (A) BACE1 or (B) APP.
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1160 HUNG AND COLEMAN
studying axonal transport. In this approach, DNA constructs
encoding transport cargoes fused with ﬂuorescent protein are
delivered to neuronal cell bodies, and the movement of the ﬂuor-
escently labelled cargoes observed directly by time-lapse imaging.
This method achieves a much higher temporal and spatial resolu-
tion than the traditional radiolabelling approach. Most importantly,
individually moving cargoes can also be tracked.32 In this study,
we showed that KIF1A is the primary anterograde motor protein
mediating the axonal transport of BACE1. To the best of our
knowledge, this is the ﬁrst study to identify the kinesin responsi-
ble for moving BACE1 using live cell imaging, a result further
supported by the dependence of BACE1 transport on levels of
functional KIF1A.
Advances in ﬂuorescence microscopy allow us to understand the
distribution and dynamics of different types of axonally transported car-
goes in living cells. We can now follow and record the movement of a
ﬂuorescently labelled cargo within axons both in vitro and in vivo in real
time.33,34 For example, the generation of transgenic mice (MitoS mice)
that expresses cyan ﬂuorescent protein targeted to mitochondria allows
us to visualise and follow the mitochondria movement in individual
axons over extended periods of time.34 Although mitochondria are use-
ful for the live imaging of axonal transport, they are not representative
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FIGURE 5 (A) Knockdown of KIF1A inhibits beta-secretase 1 (BACE1) but not mitochondria movement in axons of dissociated superior cervical
ganglions (SCG) neurons. Representative kymographs comparing transport of BACE1-mCherry between (a) control and (b) non-targeting siRNA
and (c) KIF1A siRNA neurons (upper panel). Representative kymographs comparing transport of mito-RFP between (a) control and (b) non-
targeting siRNA and (c) KIF1A siRNA neurons (bottom panel). (B) Quantiﬁcation of the number of moving BACE1-mCherry particles (control:
n = 18, non-targeting siRNA: n = 11, KIF1A siRNA: n = 11, P < .001, t-test) (left panel). Quantiﬁcation of the number of moving mitochondria-
RFP particles (control: n = 12, non-targeting siRNA: n = 10, KIF1A siRNA: n = 10) (right panel). Error bars indicate standard error of the mean
(SEM). (C) Representative immunoblots performed on cell lysates to show knockdown of KIF1A. Quantiﬁcation of the knockdown of KIF1A is
expressed as a ratio of KIF1A to Tuj1 expression. (n = 3). Error bars indicate standard error of the mean (SEM).
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of most axonal transport cargoes, as their movement may be inﬂuenced
as much by local energy demands as by transport capacity. Moreover,
only a minority of mitochondria move in axons. To address this limita-
tion, we generated a new transgenic mouse to study the axonal trans-
port of NMNAT2, which is an essential survival factor for the
maintenance of healthy axons. The transport of NMNAT2 can be
assayed in the central nervous system explants and in peripheral
nerves.35,36 Our data showed that BACE1 also moves independently of
both NMNAT2 and Mitochondria. Hence, BACE1 appears to be a use-
ful marker for studying a third, non-overlapping component of axonal
transport. A useful future research direction would be to cross the
transgenic mice expressing ﬂuorescently tagged BACE137 with both
MitoS and NMNAT2 transgenic models to simultaneously report on
multiple axonal transport motors. We could then follow the axonal
transport of three independently moving cargoes using time-lapse ima-
ging. In this way, we would be able to obtain a more comprehensive
view of how axonal transport is affected in aging36 or in models of neu-
rodegenerative diseases.38
3.2 | Retrograde transport of KIF1A and BACE1
In this study, we show that KIF1A has a high percentage of co-
migration with BACE1 in both the anterograde and retrograde
directions. As all of the axonal microtubules are orientated uniformly,
with the plus ends (polymerising ends) facing the axon terminals, the
observation in this and other studies13,14 that the plus-end driven
kinesin KIF1A is capable of moving retrogradely is rather surprising. It
has been proposed that cargoes move bidirectionally due to a tug-of-
war with oppositely directed motor proteins (ie, dynein complex)
attached to the same cargo.39,40 However, the results that both
knocking down KIF1A and expressing the T312M mutant (probably a
dominant negative) diminished BACE1 motility in both the antero-
grade and retrograde directions challenges this model. It may be that
without anterograde transport there is less BACE1 available for retro-
grade transport but this observation also ﬁts with the previously sug-
gested “co-dependence” model39 and with previous studies in which
inhibition of Drosophila Unc-104 (KIF1A) disrupts axonal transport of
dense core vesicles in both directions.41 Instead of competing
mechanically with dynein motors, we suggest that KIF1A itself could
act as a cargo for the dynein complex. Indeed, a previous study found
that KIF1A is a component of the cytoplasmic dynein complex.42 We
present the ﬁrst evidence of the bidirectional co-migration of KIF1A
and BACE1. Bidirectional transport of cargo in axons offers distinct
biological advantages. For example, it may help to overcome obsta-
cles and explore a large region of cellular space before delivering the
cargo to the most appropriate site.43
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FIGURE 6 Two-colour microscopy shows that beta-secretase 1 (BACE1)-mCherry and NMNAT2-GFP are transported in different carriers in co-
injected superior cervical ganglions (SCG) axons. (A) Representative kymographs of (a) NMNAT2-GFP, (b) BACE1-mCherry and (c) Overlay of
(a) and (b). As shown in the kymographs, the localization of mobile BACE1/NMNAT2 was mostly non-overlapping. (B) Five frames from the
time-lapse images are shown, with each channel (GFP and RFP) displayed separately. Yellow arrows mark positions of a vesicle containing only
NMNAT2-GFP. Grey arrows mark positions of a vesicle containing only BACE1-mCherry.
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3.3 | Redundancy among kinesins
As a relatively small number of kinesins have to move a much larger
number of transport cargoes, it is clear that each kinesin has multi-
ple roles. Indeed studies in knockout animals have previously impli-
cated KIF1A in the movement of synaptic vesicle precursors.44
However, it remains unclear how much redundancy exists between
different kinesins in the function of moving an individual transport
cargo. Mutation of a single kinesin in humans or mice is in many
cases sufﬁcient to cause axonal growth or degeneration phenotypes,
indicating that not all roles of the respective kinesin can be compen-
sated for by others.45–47 This includes a possible role for KIF5A in
the axonal transport of mitochondria, one of the cargoes we ﬁnd
(b) Mitochondria-RFP (a) BACE1-GFP (c) Merge 
Proximal  
BACE1-GFP 
       Distal 
Mitochondria-RFP 
t =
 2
4s
ec
 
0.0 second 
2.5 second 
5.0 second 
7.5 second 
10.0 second 
B
A
% Co-migration with NMNAT2
BACE1 Mitochondria
0
20
40
60
80
100
%
 C
o
-m
ig
ra
ti
o
n
w
it
h
 N
m
n
at
2 Anterograde
Retrograde
% Co-migration with BACE1
NMNAT2 Mitochondria
0
20
40
60
80
100
%
 C
o
-m
ig
ra
ti
o
n
w
it
h
 B
A
C
E
1
Anterograde
Retrograde
% Co-migration with Mitochondria
Nmnat2 BACE1
0
20
40
60
80
100
%
 C
o
-m
ig
ra
ti
o
n
 
w
it
h
 M
it
o
ch
o
n
d
ri
a
Anterograde
Retrograde
BACE1-GFP 
BACE1-GFP 
Mitochondria-RFP 
Mitochondria-RFP 
Proximal         Distal 
FIGURE 7 Two-colour microscopy shows that beta-secretase 1 (BACE1)-GFP and mitochondria-RFP are transported in different carriers in co-
injected SCG axons. (A) Representative kymographs of (a) BACE1-GFP, (b) mitochondria-RFP and (c) Overlay of (a) and (b). As shown in the
kymographs, the localization of mobile BACE1/NMNAT2 was mostly non-overlapping. Five frames from the time-lapse images are shown, with
each channel (GFP and RFP) displayed separately. Yellow arrows mark positions of a vesicle containing only BACE1-GFP. Grey arrows mark
positions of a vesicle containing only mitochondria-RFP. (B) Quantiﬁcation of co-migration of (a) BACE1 with NMNAT2 or mitochondria
(b) NMNAT2 with BACE1 or mitochondria (c) Mitochondria with BACE1 or NMNAT2. Error bars indicate standard error of the mean (SEM).
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FIGURE 8 Beta-secretase 1 (BACE1),
nicotinamide nucleotide adenylyltransferase
2 (NMNAT2) and mitochondria vesicles have
subtle differences in both anterograde and
retrograde transport kinetics. (A) Overlay of
the velocity frequency histograms describe
the velocity distribution of mobile BACE1
(red bars, n = 24, 905 vesicles), NMNAT2
(yellow bars, n = 21, 408 vesicles) and
mitochondria (green bars, n = 29,
443 vesicles).
TABLE 2 Summary table for the axonal transport kinetics of moving ﬂuorescently labelled BACE1, NMNAT2 and mitochondria vesicles
BACE1-mCherry Mitochondria-RFP NMNAT2-mCherry
Morphology Vesicular (tubular has been observed) Mainly tubular Vesicular
Direction Both anterograde and retrograde Mainly anterograde Mainly anterograde
Average velocity (μm/s) 1.40  0.07 (anterograde) 0.93  0.05 (anterograde) 1.21  0.07 (anterograde)
1.31  0.10 (retrograde) 0.90  0.06 (retrograde) 1.01  0.08 (retrograde)
Maximal velocity (μm/s) 2.45  0.14 1.63  0.06 1.87  0.08
BACE1, beta-secretase 1; NMNAT2, nicotinamide nucleotide adenylyltransferase 2
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shows minimal co-migration with KIF1A.48 However, there are also
indications of some functional redundancy in the movement for
example of neuroﬁlaments49 and late endosomes.50 Thus, it appears
likely that the degree of functional redundancy differs on a cargo-
by-cargo basis.
3.4 | Role of KIF1A in separating APP and BACE1
trafﬁcking
Despite intensive investigation, the location where wild-type APP
and BACE1 meet and the site of the β-cleavage are still not com-
pletely understood. In our study in SCG neurons, we found that
KIF1A has a high percentage of co-migration with BACE1 (about
70% in the anterograde direction and about 80% in the retrograde
direction) but a relatively lower percentage of co-migration with
APP (about 20% in both the anterograde and retrograde direction).
Thus, in this neuron subtype at least, overexpressed BACE1 and
APP are transported primarily by different kinesins. Moreover, we
found that most moving APP and BACE1 vesicles are non-
overlapping (Figure S4). We used dual-colour, live-cell imaging of
primary SCG neurons to visualise the co-migration of APP with
BACE1. The co-migration of APP-GFP and BACE1-mCherry was
then quantiﬁed using kymographs; only moving particles were
counted. We found that the majority (>50%) of the APP particles
were moving separately from the BACE1 particles in the antero-
grade direction. However, it should be noted that the APP construct
used in this study was tagged at the carboxy-terminal; therefore,
this method does not distinguish between the transport of full-
length APP and fragments generated by cleavage that contain the
carboxy-terminal region (CTFs). Similarly, the effect of the overex-
pression of BACE1 on APP transport is not properly understood.
Thus, the question of where APP and BACE1 meet is difﬁcult to
resolve using live imaging alone.
Our results do raise the interesting prospect that changes in
KIF1A could inﬂuence the axonal transport of BACE1, and through
this inﬂuence the intracellular site and rate of processing of APP.
Interestingly, an increase in BACE1 was paradoxically found to
lower the production of Aβ,51 leading to the suggestion that shifting
processing to the cell body, as for example by reducing KIF1A activ-
ity (Fig 4A), could be beneﬁcial. In contrast, lowering expression of
KLC leads to more Aβ generation, potentially by increasing the dwell
time of APP processing products in the axon.52 Thus, we suggest
that altering the different components of axonal transport that we
describe, may have different effects on Alzheimer’s disease
pathogenesis.
4 | MATERIALS AND METHODS
4.1 | Animals
C57BL/6JOlaHsd mice were obtained from Harlan UK (Bicester, UK).
All animal work was carried out in accordance with the Animals
(Scientiﬁc Procedures) Act, 1986, under Project License 80/2254.
4.2 | Cell cultures
4.2.1 | SCG dissection
SCGs were dissected from 0 to days old C57BL/6 (wild-type) mouse
pups. Primary neuronal cell culture medium was prepared from
DMEM (glucose: 4500 mg/L, sodium pyruvate: 110 mg/L; Sigma,
Dorset, England) to which 2 mM glutamine (Invitrogen, Paisley,
UK), 100 ng/mL 7S NGF (Invitrogen), 1% penicillin/streptomycin
(Invitrogen), 10% foetal bovine serum (Sigma) were added. 4 μM
aphidicolin (Calbiochem, Hertfordshire, UK) was also used to reduce
proliferation and viability of small numbers of non-neuronal cells. Cul-
tures were used after 5-7 days.
4.2.2 | Dissociated SCG cultures
Dissected SCG ganglia were incubated in 0.025% trypsin (Sigma) in PBS
(without CaCl2 and MgCl2) at 37C for 30 min. This was followed by incu-
bation in 0.2% collagenase type II (Gibco, Hemel Hempstead, UK) in PBS
at 37C for a further 30 min. Ganglia were then gently triturated using
a pipette. After a 2-hour pre-plating step to remove non-neuronal cells,
5000-10,000 dissociated neurons in 40 μL of primary neuronal cell cul-
ture medium were plated in a 1 cm2 poly-L-lysine and laminin-coated
area in the center of 3.5 cm ibidi μ-dishes (Thistle Scientiﬁc, Glasgow,
UK) for microinjection experiments. A further 1 mL of primary neu-
ronal cell culture medium was added after 2 hours of incubation.
Medium was changed the next day and every 2-3 days after that.
4.3 | Plasmids construct and siRNA reagents
Expression vectors encoding EGFP-tagged SCG10 and BDNF were gen-
erated by ampliﬁcation of the complete coding region of each gene using
reverse transcriptase PCR (RT-PCR) (see below) from 1 μg total RNA
from wild-type mouse brain. Products were cloned into pEGFP-N1
(BD Biosciences Clontech, Saint-Germain-en-Laye, France) to generate
SCG10-EGFP and BDNF-EGFP expression vector. Sequencing (Cogenics)
was performed to conﬁrm the absence of PCR errors. SCG10-mCherry
and BDNF-mCherry were created by replacing the EGFP coding
sequence with the mCherry coding sequence from pmCherry-NI
(Clontech, Saint-Germain-en-Laye, France). siRNA sequences direc-
ted against mouse KIF1A mRNA (ON-TARGETplus Mouse Kif1a
SMART pools L-046928-01-0005) were purchased from Dharmacon
(Thermo Scientiﬁc, Hemel Hempstead, UK). Each pool consisted of
four individual siRNAs. The target sequences (sense strand) of each
siRNA were as follows: (1) 50-ACACAUAUGUCAACGGCAA-30,
(2) 50-UGUCCAAAAUAUUGCGGUA-30 , (3) 50-GAAGGAAGUGCGC-
GAGCUA-30, (4) 50-GGAGAUUUACUGUGAGCGA-30.
ON-TARGETplus non-targeting siRNA pool (D-001810-10) pur-
chased from Dharmacon (Thermo Scientiﬁc) was used as a negative
control in experiments.
The MEK1-GFP, MEK5-GFP, JNKI-GFP, JNKII-GFP, JNKIII-GFP,
mitochondria-RFP, NMNAT2-EGFP, NMNAT2-mCherry, constructs
were kindly provided by Dr Jon Gilley and Dr Stefan Milde. The
APP-EGFP and SOD1-GFP constructs were kindly provided by Prof.
Christopher Miller, BACE1-YFP construct were kindly provided by
Professor Gopal Thinakaran. Both KIF1A-EGFP and KIF1A-T312M-
EGFP constructs were kindly provided by Dr Jae-Ran Lee.
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4.4 | Reverse transcriptase PCR
Primers used for detection of SCG10 and BDNF transcripts in SCG
neuron RNA were as follows: SCG10: 50-ATGGCTAAAACAG-
CAATGGCC-30 and 50-CCAGACAGTTCAACCTGCAG-30; BDNF: 50-
ATGACCATCCTTTTCCTTAC-30 and 50-CTTCCCCTTTTAATGGT-
CAG-30.
4.5 | Western blotting
Protein levels of KIF1A were assessed by lysing control and siRNA
expressing dissociated cortical cultures in 50 μL of phosphate
buffered saline with cOmplete, ethylenediaminetetraacetic acid
(EDTA)-free protease inhibitor cocktail tablets (Sigma-Aldrich, Dorset,
England). Protein samples were vortexed and then heated in Laemmli
buffer to 100C for 10 min. A total of 15 μl of each sample were
separated on a 12% SDS-PAGE. After transferring the gel to PVDF
membrane, the membrane was probed with a polyclonal anti-KIF1A
antibody (Abcam, Cambridge, UK; 1:1000) and a monoclonal anti-beta
tubulin antibody (Sigma; 1:2000). After three washes with PBST for
10 minutes each, bands were detected with AlexaFluor680-conjugated
anti-mouse secondary antibody (Molecular Probes, Eugene, Oregon).
Membranes were then scanned and quantiﬁed using the Odyssey ima-
ging system (LI-COR Biosciences, Lincoln, North Carolina).
4.6 | Microinjection of DNA constructs
Microinjection mixes of plasmid DNA were prepared in 0.5× PBS(−)
and passed through a Spin-X ﬁlter (Costar, Glasgow, UK). Eppendorf
Femtotips were loaded with the microinjection mix and injection was
performed using an Eppendorf 5171 transjector and 5246 micromani-
pulator system on a Zeiss Axiovert 200 microscope. All injections
were carried out directly into the nuclei of dissociated SCG neurons.
For live cell imaging, a maximum total DNA concentration of
0.05 μg/μL in the injection mix was used. A total of 75 cells were
injected per dish and imaging was performed 6-8 hours after microin-
jection. As on only the injected cells express ﬂuorescent protein, no
other marker of injection is required.
4.7 | Immunoﬂuorescence and live imaging
For immunostaining, cells were ﬁxed in 4% paraformaldehyde (PFA) in
phosphate-buffered saline (PBS) for 30 min, washed in PBS three times
and permeabilized with Triton X-100 for 5 min. The cells were then
blocked with 50% goat serum (Sigma) in PBS for 30 min and probed
with primary antibodies diluted in blocking solution for 1 hour at room
temperature. APP: Merckmillipore 22C11 at 1:200 dilution; BACE1:
Abcam ab2077 at 1:100. Cells were then washed in PBS three times
before probing with goat anti-mouse or anti-rabbit secondary antibody
coupled to Alexa Fluor 568 (1:500). Confocal images were acquired
using a Zeiss LSM780 confocal microscope with a 20× objective.
For live cell imaging, cells were transferred (on the day of ima-
ging) into imaging medium in order to improve performance and
detectability of ﬂuorescent proteins. Cells were viable and appeared
morphologically normal in imaging medium for at least 2 days. Ima-
ging medium consisted of 1.80 mM CaCl2 (Sigma), 0.25 μM Fe(NO3)3
(Sigma), 0.81 mM MgSO4 (AnalaR, Leicestershire, UK), 5.33 mM KCl
(AnalaR), 44.05 mM NaHCO3 (Sigma), 110.34 mM NaCl (AnalaR),
0.92 mM NaH2PO4 (Sigma), 4500 mg/l glucose (AnalaR), 110 mg/L
sodium pyruvate(PAA), 2 mM glutamine (Invitrogen), 100 ng/mL 7S
NGF (Invitrogen), 1% penicillin/streptomycin (Invitrogen), 4 μM aphidi-
colin (Calbiochem), 1× MEM amino acids (PAA), 30 mg/L glycine
(AnalaR) and 42 mg/L serine (Sigma) in sterile distilled water.
Neuronal lysosomes were visualized by incubation of 100 nM Lyso-
Tracker Red DND-99 (Molecular Probes, Eugene OR 97402, USA) in
fresh medium for 30 minutes at 37C. Neurons were washed and then
replaced with fresh culture medium before imaging.
Time-lapse images were acquired using an Andor wide-ﬁeld/TIRF
imaging system comprising Nikon Ti-E microscope, Nikon 100×1.49
TIRF objective, Andor laser combiner (Andor Technology Ltd.), Andor
TuCam image splitter (Andor Technology Ltd., Belfast, UK) and 2×
Andor iXon EMCCD cameras (Andor Technology Ltd., Belfast, UK).
Cultures were maintained at 37C in an OKO labs environment cham-
ber. Time-lapse images of proximal axon regions were captured for
24 seconds with a 250 ms time-lapse interval using iQ3 live cell ima-
ging software (Andor). A total of 10-12 movies from different neurons
were captured from each culture dish. The software IMAGEJ was used
for generation of kymograph and analysis of particle velocities.
4.8 | Data analysis
Statistical analyses and graph ﬁtting were performed using GRAPHPAD
PRISM 6.0 (GraphPad Software Inc., La Jolla, CA 92037 USA)
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